Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Epirium Bio Inc. has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. While there are 2 distinct examiners involved, they both operate within 1 distinct art unit. This concentration in a single art unit indicates that the company's current patent applications are being evaluated within a specific technical niche. For a practitioner, this concentration may lead to more consistent feedback across different applications due to the shared unit guidelines and internal oversight of the specified art unit.
LEE, WILLIAM Y is the busiest examiner for the portfolio, responsible for 1 pending office action. With the total pending office actions and multiple distinct examiners, the busiest examiner is managing a portion of the workload. The fact that multiple examiners are working within 1 art unit suggests that the company may encounter consistent examination standards or internal policies specific to that unit. This environment allows for a focused prosecution strategy that addresses the particular requirements of the art unit while managing relationships with different examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHENG, KAREN | 1 | 76.3% | +26.7% |
| LEE, WILLIAM Y | 1 | 47.9% | +34.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18292890 | BICYCLIC PGDH INHIBITORS AND METHODS OF MAKING AND USING | CHENG, KAREN | — |
| 18292856 | PYRROLO[2,3-b]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1623 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18292890 | BICYCLIC PGDH INHIBITORS AND METHODS OF MAKING AND USING | CHENG, KAREN | 1623 | §102§112DP | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18292856 | PYRROLO[2,3-b]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING | LEE, WILLIAM Y | 1623 | §112 | Non-Final OA | — | Pending | Jan 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial